

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.78746124 |
| 2 | DNA deamination (GO:0045006) | 8.57191031 |
| 3 | cytidine deamination (GO:0009972) | 8.38805488 |
| 4 | cytidine metabolic process (GO:0046087) | 8.38805488 |
| 5 | cytidine catabolic process (GO:0006216) | 8.38805488 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.28751945 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.10687385 |
| 8 | actin nucleation (GO:0045010) | 5.40030828 |
| 9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.37183665 |
| 10 | sequestering of actin monomers (GO:0042989) | 5.17833874 |
| 11 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 5.03308136 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.74727535 |
| 13 | macrophage chemotaxis (GO:0048246) | 4.68029967 |
| 14 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 4.54713312 |
| 15 | cytolysis (GO:0019835) | 4.46245455 |
| 16 | negative regulation of T cell apoptotic process (GO:0070233) | 4.45428412 |
| 17 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.44188728 |
| 18 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.30684925 |
| 19 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.30600859 |
| 20 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.30600859 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.29220344 |
| 22 | negative regulation by host of viral transcription (GO:0043922) | 4.15360294 |
| 23 | deoxyribonucleotide biosynthetic process (GO:0009263) | 4.14550982 |
| 24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.07375280 |
| 25 | eosinophil chemotaxis (GO:0048245) | 3.95214451 |
| 26 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.91091051 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.77000755 |
| 28 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.76644288 |
| 29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.74097204 |
| 30 | respiratory electron transport chain (GO:0022904) | 3.72124041 |
| 31 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.70144303 |
| 32 | ATP synthesis coupled proton transport (GO:0015986) | 3.70144303 |
| 33 | regulation of activation of Janus kinase activity (GO:0010533) | 3.68611055 |
| 34 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.68124639 |
| 35 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.66352585 |
| 36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.66352585 |
| 37 | electron transport chain (GO:0022900) | 3.65230167 |
| 38 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.64865913 |
| 39 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.63274123 |
| 40 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.63274123 |
| 41 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.63274123 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.61761226 |
| 43 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.59077524 |
| 44 | negative regulation of viral genome replication (GO:0045071) | 3.58880417 |
| 45 | eosinophil migration (GO:0072677) | 3.57847509 |
| 46 | positive regulation of T cell apoptotic process (GO:0070234) | 3.56520296 |
| 47 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.56308399 |
| 48 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.56308399 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.54328033 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.48925456 |
| 51 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.47453838 |
| 52 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.44401128 |
| 53 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.44401128 |
| 54 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.44211722 |
| 55 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.43854396 |
| 56 | negative regulation of oxidoreductase activity (GO:0051354) | 3.43737150 |
| 57 | positive regulation of lamellipodium assembly (GO:0010592) | 3.43007146 |
| 58 | positive regulation of translational initiation (GO:0045948) | 3.41731161 |
| 59 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.40622227 |
| 60 | positive T cell selection (GO:0043368) | 3.40585435 |
| 61 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36845830 |
| 62 | negative regulation of ligase activity (GO:0051352) | 3.36845830 |
| 63 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.34203401 |
| 64 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.30367828 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 3.29422360 |
| 66 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.28405768 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.26159147 |
| 68 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25496759 |
| 69 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.24285326 |
| 70 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.23136196 |
| 71 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.22448060 |
| 72 | regulation of T cell apoptotic process (GO:0070232) | 3.17799370 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 3.12511032 |
| 74 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.09755427 |
| 75 | T cell migration (GO:0072678) | 3.09300373 |
| 76 | deoxyribonucleotide catabolic process (GO:0009264) | 3.09241900 |
| 77 | deoxyribonucleotide metabolic process (GO:0009262) | 3.08826692 |
| 78 | deoxyribose phosphate metabolic process (GO:0019692) | 3.08303780 |
| 79 | positive regulation of cell cycle arrest (GO:0071158) | 3.07466135 |
| 80 | negative T cell selection (GO:0043383) | 3.07307066 |
| 81 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.04941316 |
| 82 | rRNA modification (GO:0000154) | 3.03166688 |
| 83 | deoxyribose phosphate catabolic process (GO:0046386) | 2.98876966 |
| 84 | cellular response to interferon-beta (GO:0035458) | 2.95159602 |
| 85 | signal peptide processing (GO:0006465) | 2.93348846 |
| 86 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.93181297 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93172998 |
| 88 | purine nucleotide salvage (GO:0032261) | 2.92040509 |
| 89 | positive thymic T cell selection (GO:0045059) | 2.91937125 |
| 90 | response to interferon-beta (GO:0035456) | 2.90099222 |
| 91 | ubiquinone biosynthetic process (GO:0006744) | 2.87596089 |
| 92 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.86314199 |
| 93 | protein maturation by protein folding (GO:0022417) | 2.84635327 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.82562142 |
| 95 | rRNA methylation (GO:0031167) | 2.81845328 |
| 96 | positive regulation of cell killing (GO:0031343) | 2.80359040 |
| 97 | positive regulation of defense response to virus by host (GO:0002230) | 2.80024015 |
| 98 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.79785288 |
| 99 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.77082450 |
| 100 | positive regulation of ligase activity (GO:0051351) | 2.75794929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.75133680 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.01834637 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.81047792 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.09238702 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.69137562 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59672961 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.47215437 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.34982510 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85154548 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79200089 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.71339261 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.60306722 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.58802598 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.49914152 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46754324 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41993896 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.31473173 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.19788457 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17330480 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.05627861 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99832462 |
| 22 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96905373 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94652450 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.91074176 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.83013547 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.79438929 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79195224 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73262381 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72371995 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.69611558 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69129372 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65653843 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65268328 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.60209469 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57777652 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57654614 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55125467 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54425816 |
| 39 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.46363907 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44623155 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.42269994 |
| 42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41795059 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41711677 |
| 44 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.39636531 |
| 45 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.37879357 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37580142 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32403917 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.31499749 |
| 49 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31000602 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30516658 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.28927583 |
| 52 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28295030 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28212224 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24742249 |
| 55 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19628127 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19547741 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17925983 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17656737 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16530055 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16139730 |
| 61 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15620774 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15153238 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14659450 |
| 64 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14021533 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12580916 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11403240 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10936169 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09185689 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07218155 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07148363 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05484197 |
| 72 | AR_20517297_ChIP-Seq_VCAP_Human | 1.00572517 |
| 73 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00072786 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97539848 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97539848 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97204171 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95517309 |
| 78 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95176966 |
| 79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94865835 |
| 80 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.93408191 |
| 81 | P300_27268052_Chip-Seq_Bcells_Human | 0.93216353 |
| 82 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93168643 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93114599 |
| 84 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.92819543 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91177661 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91177661 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90920003 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.90282139 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89435183 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.89091422 |
| 91 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88945576 |
| 92 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.88938236 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87302311 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86989375 |
| 95 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86633116 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86577536 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86500248 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86484235 |
| 99 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.85100539 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84810978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.57589804 |
| 2 | MP0009785_altered_susceptibility_to | 3.58455649 |
| 3 | MP0009333_abnormal_splenocyte_physiolog | 3.29723572 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.13868968 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.76761767 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.71994106 |
| 7 | MP0006082_CNS_inflammation | 2.69547179 |
| 8 | MP0005451_abnormal_body_composition | 2.68538134 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.56391917 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.42836787 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.39049068 |
| 12 | MP0002006_tumorigenesis | 2.38221938 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 2.18351590 |
| 14 | MP0005387_immune_system_phenotype | 2.16776880 |
| 15 | MP0001790_abnormal_immune_system | 2.16776880 |
| 16 | MP0001800_abnormal_humoral_immune | 2.13957924 |
| 17 | MP0005025_abnormal_response_to | 2.07674362 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.03684292 |
| 19 | MP0001819_abnormal_immune_cell | 1.95912415 |
| 20 | MP0002723_abnormal_immune_serum | 1.92330763 |
| 21 | MP0001873_stomach_inflammation | 1.89111707 |
| 22 | MP0002163_abnormal_gland_morphology | 1.85202493 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.81834478 |
| 24 | MP0003252_abnormal_bile_duct | 1.81182030 |
| 25 | MP0003283_abnormal_digestive_organ | 1.78920175 |
| 26 | MP0009697_abnormal_copulation | 1.77401990 |
| 27 | MP0000685_abnormal_immune_system | 1.75124376 |
| 28 | MP0004147_increased_porphyrin_level | 1.74975874 |
| 29 | MP0010386_abnormal_urinary_bladder | 1.74437039 |
| 30 | MP0003786_premature_aging | 1.70792049 |
| 31 | MP0003448_altered_tumor_morphology | 1.69644527 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.68005820 |
| 33 | MP0003866_abnormal_defecation | 1.66803690 |
| 34 | MP0002405_respiratory_system_inflammati | 1.64638387 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.62044346 |
| 36 | MP0002933_joint_inflammation | 1.54524963 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.54412113 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.51815723 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.45875725 |
| 40 | MP0000716_abnormal_immune_system | 1.45523509 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.44145738 |
| 42 | MP0002398_abnormal_bone_marrow | 1.43993727 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.43791852 |
| 44 | MP0002160_abnormal_reproductive_system | 1.39933062 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.39541469 |
| 46 | MP0005551_abnormal_eye_electrophysiolog | 1.38417940 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.36384745 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.34666570 |
| 49 | MP0002736_abnormal_nociception_after | 1.34404704 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.33091003 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.30903215 |
| 52 | MP0002722_abnormal_immune_system | 1.30195644 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.27503935 |
| 54 | MP0005389_reproductive_system_phenotype | 1.21244823 |
| 55 | MP0010094_abnormal_chromosome_stability | 1.17746820 |
| 56 | MP0002429_abnormal_blood_cell | 1.17018963 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.15801719 |
| 58 | MP0002419_abnormal_innate_immunity | 1.14122581 |
| 59 | MP0001919_abnormal_reproductive_system | 1.13627196 |
| 60 | MP0001905_abnormal_dopamine_level | 1.09539226 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.09411836 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08585480 |
| 63 | MP0001661_extended_life_span | 1.08540559 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.08353973 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.05268684 |
| 66 | MP0002693_abnormal_pancreas_physiology | 1.01892268 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.00710569 |
| 68 | MP0001501_abnormal_sleep_pattern | 0.99604291 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92970240 |
| 70 | MP0003045_fibrosis | 0.91493032 |
| 71 | MP0003436_decreased_susceptibility_to | 0.91264213 |
| 72 | MP0010155_abnormal_intestine_physiology | 0.90168530 |
| 73 | MP0005083_abnormal_biliary_tract | 0.89986634 |
| 74 | MP0003137_abnormal_impulse_conducting | 0.89378916 |
| 75 | MP0008469_abnormal_protein_level | 0.88513708 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.87317775 |
| 77 | MP0003878_abnormal_ear_physiology | 0.87317775 |
| 78 | MP0008260_abnormal_autophagy | 0.86388524 |
| 79 | MP0001666_abnormal_nutrient_absorption | 0.82205408 |
| 80 | MP0001188_hyperpigmentation | 0.80791478 |
| 81 | MP0006292_abnormal_olfactory_placode | 0.79581843 |
| 82 | MP0005360_urolithiasis | 0.76776177 |
| 83 | MP0008872_abnormal_physiological_respon | 0.76187670 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.75022814 |
| 85 | MP0009763_increased_sensitivity_to | 0.74888352 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.74126954 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.72795212 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.72668170 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.71567925 |
| 90 | MP0003646_muscle_fatigue | 0.70188191 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.69050898 |
| 92 | MP0008058_abnormal_DNA_repair | 0.68593511 |
| 93 | MP0004947_skin_inflammation | 0.67016174 |
| 94 | MP0004742_abnormal_vestibular_system | 0.66095493 |
| 95 | MP0002102_abnormal_ear_morphology | 0.65588813 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.62884002 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.61706030 |
| 98 | MP0008932_abnormal_embryonic_tissue | 0.60645049 |
| 99 | MP0001853_heart_inflammation | 0.58674199 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.58192290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 5.80824794 |
| 2 | Increased IgM level (HP:0003496) | 5.39841579 |
| 3 | Abnormality of B cell number (HP:0010975) | 5.27603989 |
| 4 | T lymphocytopenia (HP:0005403) | 5.20947788 |
| 5 | Aplastic anemia (HP:0001915) | 5.02134049 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 5.02052007 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.80108028 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51519890 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.28134622 |
| 10 | IgG deficiency (HP:0004315) | 4.22391402 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.98734757 |
| 12 | Thyroiditis (HP:0100646) | 3.89318681 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.84521245 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.81204159 |
| 15 | Hepatic necrosis (HP:0002605) | 3.77130820 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.63319809 |
| 17 | Acute hepatic failure (HP:0006554) | 3.60916333 |
| 18 | Pancytopenia (HP:0001876) | 3.56409204 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.41098580 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40163091 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40163091 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.33784838 |
| 23 | Chronic diarrhea (HP:0002028) | 3.25317026 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.24133256 |
| 25 | Abnormality of T cells (HP:0002843) | 3.16398048 |
| 26 | Generalized aminoaciduria (HP:0002909) | 3.11313184 |
| 27 | Lipid accumulation in hepatocytes (HP:0006561) | 3.11028559 |
| 28 | Increased CSF lactate (HP:0002490) | 3.10225886 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.03961439 |
| 30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.02406310 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 3.01520072 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.95206720 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.89518034 |
| 34 | Encephalitis (HP:0002383) | 2.77195662 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 2.76740975 |
| 36 | Lymphopenia (HP:0001888) | 2.72905389 |
| 37 | Acute encephalopathy (HP:0006846) | 2.72159687 |
| 38 | Hypergammaglobulinemia (HP:0010702) | 2.71913615 |
| 39 | Hypoproteinemia (HP:0003075) | 2.71609061 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.70091638 |
| 41 | Increased muscle lipid content (HP:0009058) | 2.64734595 |
| 42 | Abnormality of eosinophils (HP:0001879) | 2.63947004 |
| 43 | Amyotrophic lateral sclerosis (HP:0007354) | 2.55474613 |
| 44 | Renal Fanconi syndrome (HP:0001994) | 2.52750677 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48934574 |
| 46 | Stomatitis (HP:0010280) | 2.46378754 |
| 47 | Increased serum lactate (HP:0002151) | 2.44761070 |
| 48 | Clubbing of toes (HP:0100760) | 2.41624491 |
| 49 | Abnormality of the renal collecting system (HP:0004742) | 2.41255032 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.38191696 |
| 51 | Abnormality of the prostate (HP:0008775) | 2.37794588 |
| 52 | IgM deficiency (HP:0002850) | 2.37783962 |
| 53 | Optic disc pallor (HP:0000543) | 2.36175642 |
| 54 | Decreased central vision (HP:0007663) | 2.34545569 |
| 55 | Eosinophilia (HP:0001880) | 2.27602494 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.25329751 |
| 57 | Lactic acidosis (HP:0003128) | 2.23392784 |
| 58 | Duplicated collecting system (HP:0000081) | 2.23171820 |
| 59 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.22646713 |
| 60 | Cerebral edema (HP:0002181) | 2.22060395 |
| 61 | Recurrent viral infections (HP:0004429) | 2.19339277 |
| 62 | Respiratory failure (HP:0002878) | 2.19012631 |
| 63 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.14719346 |
| 64 | Abnormality of the ileum (HP:0001549) | 2.14455189 |
| 65 | Joint swelling (HP:0001386) | 2.13841376 |
| 66 | Lymphoma (HP:0002665) | 2.13739743 |
| 67 | Meckel diverticulum (HP:0002245) | 2.12179297 |
| 68 | Exertional dyspnea (HP:0002875) | 2.11688274 |
| 69 | Hypoplasia of the thymus (HP:0000778) | 2.08875343 |
| 70 | Colon cancer (HP:0003003) | 2.08039807 |
| 71 | Retinal dysplasia (HP:0007973) | 2.07948526 |
| 72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04583592 |
| 73 | Keratoconus (HP:0000563) | 1.99828124 |
| 74 | Increased corneal curvature (HP:0100692) | 1.99828124 |
| 75 | Abnormality of macrophages (HP:0004311) | 1.98240525 |
| 76 | Glycosuria (HP:0003076) | 1.97850831 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 1.97850831 |
| 78 | Granulocytopenia (HP:0001913) | 1.97386348 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.96703894 |
| 80 | Absent thumb (HP:0009777) | 1.95251397 |
| 81 | Cerebral palsy (HP:0100021) | 1.92498934 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92381431 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 1.92381431 |
| 84 | Methylmalonic acidemia (HP:0002912) | 1.88224855 |
| 85 | Leukocytosis (HP:0001974) | 1.87006610 |
| 86 | Meningitis (HP:0001287) | 1.86397532 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 1.84355233 |
| 88 | CNS demyelination (HP:0007305) | 1.84226813 |
| 89 | Pendular nystagmus (HP:0012043) | 1.80921466 |
| 90 | Recurrent fungal infections (HP:0002841) | 1.80560193 |
| 91 | Chromsome breakage (HP:0040012) | 1.79422647 |
| 92 | Cellular immunodeficiency (HP:0005374) | 1.78825484 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.78667344 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 1.78667344 |
| 95 | Abnormality of the preputium (HP:0100587) | 1.77668378 |
| 96 | Episodic fever (HP:0001954) | 1.76594873 |
| 97 | Congenital stationary night blindness (HP:0007642) | 1.76482907 |
| 98 | Erythema (HP:0010783) | 1.74211734 |
| 99 | Bronchitis (HP:0012387) | 1.71413158 |
| 100 | Renal cortical cysts (HP:0000803) | 1.70824141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.45368911 |
| 2 | TESK2 | 5.63282404 |
| 3 | MAP3K12 | 3.33301419 |
| 4 | VRK2 | 2.78784178 |
| 5 | TESK1 | 2.78455909 |
| 6 | LIMK1 | 2.49200186 |
| 7 | BCKDK | 2.48789775 |
| 8 | BUB1 | 2.46046491 |
| 9 | TXK | 2.30499510 |
| 10 | TAOK3 | 2.24404504 |
| 11 | ITK | 2.22168709 |
| 12 | STK16 | 2.16314951 |
| 13 | WNK4 | 2.11224727 |
| 14 | MAP3K11 | 2.04711819 |
| 15 | ZAK | 1.86775488 |
| 16 | MAP4K1 | 1.85698987 |
| 17 | EIF2AK3 | 1.76561485 |
| 18 | NUAK1 | 1.67612950 |
| 19 | MAP4K2 | 1.62072140 |
| 20 | DAPK1 | 1.55457077 |
| 21 | ADRBK2 | 1.55131621 |
| 22 | MST4 | 1.50383667 |
| 23 | PINK1 | 1.48952577 |
| 24 | VRK1 | 1.47980742 |
| 25 | TLK1 | 1.45411482 |
| 26 | TAF1 | 1.44079151 |
| 27 | TEC | 1.39410490 |
| 28 | IKBKE | 1.38155276 |
| 29 | PRKCQ | 1.31372778 |
| 30 | STK39 | 1.20432414 |
| 31 | BLK | 1.12687644 |
| 32 | EIF2AK1 | 1.11977366 |
| 33 | NEK1 | 1.07640201 |
| 34 | SYK | 1.04223325 |
| 35 | GRK1 | 1.04188784 |
| 36 | RPS6KA4 | 1.02768778 |
| 37 | BCR | 1.02029189 |
| 38 | ZAP70 | 1.01139655 |
| 39 | MAPKAPK3 | 0.90562984 |
| 40 | GRK7 | 0.84414336 |
| 41 | MYLK | 0.82693182 |
| 42 | CDK8 | 0.82171538 |
| 43 | WEE1 | 0.76505120 |
| 44 | TBK1 | 0.76217074 |
| 45 | GRK5 | 0.75528041 |
| 46 | LCK | 0.73872314 |
| 47 | FES | 0.72096909 |
| 48 | CSF1R | 0.70839554 |
| 49 | PIK3CA | 0.70312245 |
| 50 | CAMKK2 | 0.66721441 |
| 51 | CSK | 0.66714991 |
| 52 | RPS6KA5 | 0.66287127 |
| 53 | FRK | 0.65131670 |
| 54 | OXSR1 | 0.62762093 |
| 55 | BTK | 0.61258246 |
| 56 | ERBB3 | 0.61232974 |
| 57 | DYRK2 | 0.61212745 |
| 58 | BMPR1B | 0.59088329 |
| 59 | AURKA | 0.57391290 |
| 60 | CSNK1G3 | 0.54730026 |
| 61 | LYN | 0.54289332 |
| 62 | WNK3 | 0.53300332 |
| 63 | TRPM7 | 0.52942895 |
| 64 | KIT | 0.49671703 |
| 65 | TNK2 | 0.49603149 |
| 66 | PLK4 | 0.47246673 |
| 67 | INSRR | 0.44745052 |
| 68 | CDC7 | 0.43850592 |
| 69 | DAPK2 | 0.43343853 |
| 70 | NME1 | 0.43048618 |
| 71 | PRKD3 | 0.42954182 |
| 72 | EIF2AK2 | 0.40596681 |
| 73 | CLK1 | 0.39890521 |
| 74 | CSNK1A1L | 0.39870746 |
| 75 | ROCK1 | 0.39157590 |
| 76 | CSNK1A1 | 0.39059084 |
| 77 | AURKB | 0.38037110 |
| 78 | PAK1 | 0.36109928 |
| 79 | TRIM28 | 0.35607110 |
| 80 | CSNK2A1 | 0.35062107 |
| 81 | ATR | 0.34683467 |
| 82 | PIK3CG | 0.34607657 |
| 83 | MAPKAPK2 | 0.32602605 |
| 84 | AKT3 | 0.32326352 |
| 85 | CDK7 | 0.32319105 |
| 86 | PLK1 | 0.32068577 |
| 87 | MUSK | 0.31886932 |
| 88 | CDK18 | 0.29818379 |
| 89 | CSNK1G1 | 0.29381231 |
| 90 | SMG1 | 0.29096713 |
| 91 | PRKCA | 0.28799094 |
| 92 | DAPK3 | 0.27840121 |
| 93 | CDK15 | 0.27478824 |
| 94 | PASK | 0.27260586 |
| 95 | IKBKB | 0.26457422 |
| 96 | FLT3 | 0.26298740 |
| 97 | TIE1 | 0.25143583 |
| 98 | CDK14 | 0.24696896 |
| 99 | OBSCN | 0.24669103 |
| 100 | STK10 | 0.24227920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.29421288 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.15853974 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.60991761 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.25642345 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.96888370 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.78044681 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.59244166 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.50731912 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.48499494 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.10469734 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10315157 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09368277 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06806227 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.02483808 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.96111466 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.88234294 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88064449 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.80578124 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74427176 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69111381 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.58098782 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.50446172 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.46875215 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42018615 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40300190 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30211895 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30170243 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25572888 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.24416283 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.21259954 |
| 31 | Ribosome_Homo sapiens_hsa03010 | 1.20290691 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18951977 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.18613346 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15688135 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.05295290 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04521981 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01358355 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93980744 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.91264391 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.90306604 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86166386 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 0.85603434 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82764924 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78415160 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 0.77414946 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 0.77144479 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76503450 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76115862 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70145125 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65606979 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65431478 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.64520052 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64114378 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63432483 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62296461 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61134489 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60628255 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58551592 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58478734 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.57916645 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56630479 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54354942 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52891872 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51715755 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51681943 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50742944 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49063875 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47465799 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47394095 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46384944 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46092944 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43856499 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43520084 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43354580 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.37264270 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35983051 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35460343 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35030850 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.34510487 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.33912987 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32945706 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31363325 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30911007 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.30351449 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28854389 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28849819 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26937398 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26594053 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26100379 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.25774640 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24801194 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24417472 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23036647 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23005336 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21532380 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.19946714 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.19116158 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16517340 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16362853 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16359953 |

